Prestige Consumer Healthcare
PBH
#4607
Rank
A$3.30 B
Marketcap
A$69.73
Share price
0.64%
Change (1 day)
-24.11%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): A$5.29

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$5.10. In 2025 the company made an earnings per share (EPS) of A$5.42 a decrease over its 2024 EPS that were of A$6.11.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.29-2.25%
2025A$5.42-11.4%
2024A$6.11-367.08%
2023A-$2.29-138.33%
2022A$5.9711.7%
2021A$5.3413.6%
2020A$4.70-651.67%
2019A-$0.85-148.78%
2018A$1.75-83.29%
2017A$10.46437.23%
2016A$1.95-34.13%
2015A$2.9652.94%
2014A$1.93-8.11%
2013A$2.10
2011A$1.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.41 143.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$9.61 88.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.47 85.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.08-78.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.43-13.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$8.78 72.14%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$3.28-35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.55-10.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$42.10-925.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.73-66.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel